A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions
Episodic Cluster Headache
Interventions
DRUG

Civamide (Zucapsaicin)

Trial Locations (26)

10021

New York Headache Center, New York

19107

Jefferson Headache Center, Philadelphia

22304

The Neurology and Headache Treatment Center (Innovative Clinical Research), Alexandria

27401

The Headache Wellness Center, Greensboro

30033

Neurology and Headache Specialists of Atlanta, Decatur

33324

Neurology Clinical Research, Inc., Plantation

37203

Nashville Neuroscience Center, Nashville

44195

Cleveland Clinic Foundation, Cleveland

45219

Cincinnati Headache Clinic, Cincinnati

48104

Michigan Headache Pain & Neurological Institute, Ann Arbor

48202

Henry Ford Hospital Department of Neurology, Detroit

55905

Department of Neurology Mayo Clinic, Rochester

60614

Diamond Headache Clinic, Chicago

63017

Mercy Health Research, Chesterfield

65804

Headache Care Center/Clinvest, Springfield

73104

University of Oklahoma, Oklahoma City

74136

Neurological Associates of Tulsa, Inc., Tulsa

77004

Houston Headache Clinic, Houston

85020

Valley Neurological Headache & Research Center, Phoenix

85712

Neurological Associates of Tucson, Tucson

90404

California Medical Clinic for Headache, Santa Monica

94040

Northern California Headache Clinic, Mountain View

94109

San Francisco Clinical Research Center, San Francisco

06902

New England Center for Headache, PC, Stamford

02481

Boston Clinical Research Center, Wellesley Hills

03756

Dartmouth Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Winston Laboratories

INDUSTRY

NCT00033839 - A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache | Biotech Hunter | Biotech Hunter